DTx Alliance
- "Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a broad spectrum of physical, mental, and behavioral conditions. Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape, and are distinct from pure-play adherence, diagnostic, and telehealth products."
- "The arrival of digital therapeutics—an emerging health discipline that uses technology to augment or even replace active drugs in disease treatment—is reshaping the landscape for new medicines, product reimbursement and regulatory oversight." (Includes 4 primary methods to validate DTx)
Reports
DTx Alliance September 2018
Digital therapeutics: Preparing for takeoff [insight report]
McKinsey & Co February 2018
